Musarat Kabir
Papers
1
Total Citations
127
H-Index
1
About
Musarat Kabir is a leading researcher in bioanalytical chemistry, with a primary focus on the development of innovative mass spectrometry-based methods for quantifying therapeutic targets and biomarkers. Her most cited work, a 2012 study with 127 citations, centers on a groundbreaking sequential protein and peptide immunoaffinity capture technique for the precise quantification of human β-Nerve Growth Factor (NGF). This contribution is particularly significant in the field of pain research, as NGF is a key neurotrophin implicated in chronic pain modulation. Kabir’s method was instrumental in supporting the clinical development of tanezumab, a humanized monoclonal antibody that sequesters NGF and has shown strong efficacy in treating chronic pain. By enabling accurate, sensitive measurement of total NGF in complex biological samples, her work provided a critical tool for pharmacokinetic and pharmacodynamic studies. This achievement highlights Kabir’s impact at the intersection of analytical chemistry and translational medicine, offering a robust platform for advancing targeted therapies and biomarker quantification in drug development.
Research Focus
Key Achievements
Top Papers
- 1